Last $32.73 USD
Change Today -0.80 / -2.39%
Volume 17.1K
OFIX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 10:21 AM 07/28/14 All times are local (Market data is delayed by at least 15 minutes).

orthofix international nv (OFIX) Snapshot

Open
$33.53
Previous Close
$33.53
Day High
$33.53
Day Low
$32.73
52 Week High
07/2/14 - $36.90
52 Week Low
10/9/13 - $19.35
Market Cap
603.4M
Average Volume 10 Days
89.6K
EPS TTM
$0.12
Shares Outstanding
18.4M
EX-Date
--
P/E TM
273.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for ORTHOFIX INTERNATIONAL NV (OFIX)

orthofix international nv (OFIX) Related Businessweek News

No Related Businessweek News Found

orthofix international nv (OFIX) Details

Orthofix International N.V., a medical device company, designs, develops, manufactures, markets, and distributes medical devices used principally by musculoskeletal medical specialists for spine and orthopedic applications. The company operates in four segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim segment offers a range of devices for use as adjunctive treatment to enhance fusion success in cervical and lumbar spine fusion, as well as a therapeutic treatment for non-healing fractures outside of the spine. The Biologics segment provides a portfolio of regenerative products that allow physicians to treat a range of spinal and orthopedic conditions under the Trinity Evolution and Trinity Elite names. The Extremity Fixation segment offers orthopedic products used in fracture repair, deformity correction, and bone reconstruction. The Spine Fixation segment provides a range of implant products used in surgical procedures of the spine. The company markets and distributes its products directly to hospitals, doctors, and other healthcare providers in the United States, the United Kingdom, Italy, Germany, Switzerland, Austria, France, Belgium, Brazil, Australia, and Puerto Rico, as well as through independent distributors, sales representatives, and affiliates in other markets. Orthofix International N.V. was founded in 1987 and is headquartered in Curaçao, the Netherlands Antilles.

889 Employees
Last Reported Date: 03/31/14
Founded in 1987

orthofix international nv (OFIX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $452.8K
President of Global Extremity Fixation
Total Annual Compensation: $437.2K
Chief Strategy Officer
Total Annual Compensation: $460.0K
Chief Administrative Officer, General Counsel...
Total Annual Compensation: $455.0K
Compensation as of Fiscal Year 2013.

orthofix international nv (OFIX) Key Developments

Orthofix International N.V. Appoints Mark Heggestad as CFO

Orthofix International N.V. has appointed Mark Heggestad as its new CFO. Mr. Heggestad will succeed David Ziegler, who has been serving as Interim CFO. Mr. Ziegler will assist Mr. Heggestad in his transition and continue to provide consulting services to the company. Mr. Heggestad previously served as Executive vice president and CFO at American Medical Systems Holdings Inc. where his supervisory responsibilities included Finance & Accounting, Investor Relations, Internal Auditing, IT, Business Development and Strategic Planning among others. Prior to this he held a variety of executive and management roles at Medtronic Inc., including vice president of Finance and IT for the Cardiac Surgery Business, vice president of Corporate Audit & Compliance Assurance and vice president of Corporate Finance, Assistant Controller. Before joining Medtronic, Mr. Heggestad worked as an audit manager for KPMG.

Orthofix International N.V. Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2014

Orthofix International N.V. reported consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported net sales were $101.3 million, decreasing 2.0% from net sales of $103.4 million in the first quarter of 2013. Net loss from continuing operations was $0.2 million, or $0.01 per diluted share, compared to net income of $7.6 million, or $0.39 per diluted share for the same period last year. Adjusted net income from continuing operations was $5.2 million, or $0.29 per diluted share, compared to $7.2 million, or $0.37 per diluted share, in the first quarter 2013.

Orthofix International N.V. Presents at Jefferies 2014 Global Healthcare Conference, Jun-05-2014 02:00 PM

Orthofix International N.V. Presents at Jefferies 2014 Global Healthcare Conference, Jun-05-2014 02:00 PM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Bradley R. Mason, Chief Executive Officer, President and Director, Mark Quick, Director of Investor Relations.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OFIX:US $32.73 USD -0.80

OFIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $1.37 USD +0.019
K2M Group Holdings Inc $16.08 USD -0.11
LDR Holding Corp $22.26 USD +0.42
RTI Surgical Inc $4.50 USD -0.08
Wright Medical Group Inc $30.68 USD -0.62
View Industry Companies
 

Industry Analysis

OFIX

Industry Average

Valuation OFIX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.5x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORTHOFIX INTERNATIONAL NV, please visit www.orthofix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.